
KALA BIO, Inc.
KALA BIO, Inc.(KALA)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kala · 股价预测 · 9 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$35.00
Consensus
$18.25
+652.5% upside
Low
$1.50
Median: $18.25 · Last Close: $2.43
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$18.25
652.5% upside
High Target
$35
1343.1%
Low Target
$1.5
-38.2%
Current Price
$2.43
as of today
Based on analyst price targets, the KALA stock price prediction for the next 12 months ranges from $1.5 to $35. The consensus KALA price forecast of $18.25 implies 652.5% upside from the current price of $2.43.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.30 | ↓ 5.00% |
1-day model range: $2.26–$2.35. Peak: $2.35 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KALA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-09-29 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-09-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-11 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-05-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-19 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-05-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on KALA BIO, Inc. (KALA) stock. Of the recent 48 rating actions, 0 were upgrades and 5 were downgrades. 9 analysts currently cover KALA.
分析师推荐趋势
KALA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$41M
↑ 58.3% YoY
Revenue Next Year
$25M
↓ 39.5% YoY
EPS This Year
$-222.50
EPS Next Year
$-26.50
↓ 88.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast KALA EPS of $-222.50 for the current fiscal year, based on estimates from 1 analysts. The KALA revenue forecast is $41M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KALA 股价预测由两类独立数据源支撑:来自 9 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。KALA 的共识目标价为 $18.25(+652.5% 上行空间),分析师共识为 Buy。
KALA 的短期预测(明日)为 $2.30(-5.00%)。
KALA BIO, Inc. 在 NASDAQ 上市,代码 KALA。KALA 在 2027 年的整体展望偏积极,在覆盖分析师中约 56% 对应 Buy 共识。
常见问题
KALA 预测 · 8 个问题根据 9 位华尔街分析师,KALA 的 12 个月平均目标价为 $18.25,最高 $35.00、最低 $1.50。若有图表,中位目标价可在上方查看。相对当前价 $2.43,隐含约 +652.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.